Sanozen Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 11-12-2024
- Paid Up Capital ₹ 0.24 M
as on 11-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.24%
(FY 2023)
- Profit 73.96%
(FY 2023)
- Ebitda 212.26%
(FY 2023)
- Net Worth -9.49%
(FY 2023)
- Total Assets -1.16%
(FY 2023)
About Sanozen Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.24 M, as per Ministry of Corporate Affairs (MCA) records.
Manikya Kodali and Vijayaprakash Katikala serve as directors at the Company.
- CIN/LLPIN
U24239TG2016PTC110123
- Company No.
110123
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2016
- Date of AGM
12 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanozen Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manikya Kodali  | Director | 12-Jun-2023 | Current |
| Vijayaprakash Katikala | Director | 12-Jun-2023 | Current |
Financial Performance of Sanozen Pharma.
Sanozen Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.24% decrease. The company also saw a substantial improvement in profitability, with a 73.96% increase in profit. The company's net worth dipped by a decrease of 9.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanozen Pharma?
In 2023, Sanozen Pharma had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sppt Chem Private LimitedActive 10 years 11 monthsManikya Kodali and Vijayaprakash Katikala are mutual person
- Sp Labs Private LimitedActive 10 years 4 months
Manikya Kodali and Vijayaprakash Katikala are mutual person
- Sp Accure Labs Private LimitedActive 11 years 2 months
Manikya Kodali and Vijayaprakash Katikala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanozen Pharma?
Unlock and access historical data on people associated with Sanozen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanozen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
